Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly.
Nathalie Journiac1, Javier Gilabert-Juan1, Sara Cipriani1
1Université de Paris, NeuroDiderot, Inserm, 75019 Paris, France.
Cell Reports
|April 16, 2020
Summary
The microcephaly gene Mcph1 regulates brain size by controlling neural progenitor cell proliferation and survival. This study reveals its role in mitochondrial activity and glutaminolysis, suggesting metabolic pathway alterations cause microcephaly.
Area of Science:
- Neuroscience
- Developmental Biology
- Cell Biology
Background:
- Neocortical development involves coordinated progenitor cell production for neurogenesis and brain size.
- Microcephaly is a condition characterized by an abnormally small brain, often linked to genetic factors.
Purpose of the Study:
- To investigate the function of the microcephaly gene Mcph1 in neocortical development.
- To elucidate the molecular mechanisms by which Mcph1 influences neural progenitor cell behavior and brain growth.
Main Methods:
- Studied Mcph1 function in mouse models during neocortical development.
- Examined Mcph1 expression and localization within neural progenitor cells.
- Investigated the impact of Mcph1 on cell proliferation, survival, and mitochondrial activity.
Main Results:
- Mcph1 functions in apical radial glial cells (aRGCs) before indirect neurogenesis.
- Mcph1 is localized to mitochondria and regulates RGC proliferation and survival.
- Mcph1 potentially interacts with cellular metabolic pathways, including mitochondrial activity and glutaminolysis.
Conclusions:
- Mcph1 plays a critical role in regulating neocortical growth through its influence on neural progenitor cell dynamics.
- The study implicates alterations in cellular metabolic pathways, particularly glutaminolysis, in the pathogenesis of microcephaly.
- Mcph1 links bioenergetic pathways to neocortical development, offering insights into microcephaly causes.
Related Concept Videos
01:20Inborn Errors of Metabolism
627
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
627
01:46Electron Transport Chain: Complex I and II
18.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.2K